- Home
- DTST vs TPST Comparison
DTST vs TPST Comparison
Compare DTST & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- TPST
- Stock Information
- Founded
- DTST 2001
- TPST 2011
- Country
- DTST United States
- TPST United States
- Employees
- DTST N/A
- TPST N/A
- Industry
- DTST EDP Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- TPST Health Care
- Exchange
- DTST Nasdaq
- TPST Nasdaq
- Market Cap
- DTST 33.4M
- TPST 33.0M
- IPO Year
- DTST N/A
- TPST N/A
- Fundamental
- Price
- DTST $4.66
- TPST $7.54
- Analyst Decision
- DTST
- TPST Hold
- Analyst Count
- DTST 0
- TPST 3
- Target Price
- DTST N/A
- TPST $30.00
- AVG Volume (30 Days)
- DTST 977.3K
- TPST 94.0K
- Earning Date
- DTST 08-13-2025
- TPST 08-11-2025
- Dividend Yield
- DTST N/A
- TPST N/A
- EPS Growth
- DTST N/A
- TPST N/A
- EPS
- DTST 0.02
- TPST N/A
- Revenue
- DTST $25,219,312.00
- TPST N/A
- Revenue This Year
- DTST $12.57
- TPST N/A
- Revenue Next Year
- DTST $9.29
- TPST N/A
- P/E Ratio
- DTST $199.27
- TPST N/A
- Revenue Growth
- DTST N/A
- TPST N/A
- 52 Week Low
- DTST $2.93
- TPST $5.35
- 52 Week High
- DTST $5.57
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- DTST 59.10
- TPST 56.78
- Support Level
- DTST $4.54
- TPST $7.13
- Resistance Level
- DTST $5.42
- TPST $8.75
- Average True Range (ATR)
- DTST 0.33
- TPST 0.47
- MACD
- DTST 0.02
- TPST 0.12
- Stochastic Oscillator
- DTST 62.68
- TPST 54.17
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.